Search
Search Results
##search.searchResults.foundPlural##
-
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1637PDF: 883HTML: 386 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1765PDF: 1207HTML: 278 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3897PDF: 1002HTML: 6897 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3979PDF: 1722HTML: 894Figures . Eliassian: 336 -
TREATMENT OF NEWLY DIAGNOSED POEMS SYNDROME: BORTEZOMIB OR LENALIDOMIDE? EXPERIENCE FROM TWO COUNTRIES
106PDF: 54Suppl. Files: 19Html: 15Html Suppl. Files: 4 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3527PDF: 1038HTML: 4986 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
3089PDF: 1367HTML: 2854Figure 1: 232 -
Flow Cytometry Method as a Diagnostic Tool for Pleural Fluid Involvement in a Patient with Multiple Myeloma
1605PDF: 805HTML: 4608Figure 1: Chest radiograph: 282Figure 2: Flow cytometer analysis of pleural fluid: 243 -
HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation
1457PDF: 941HTML: 283 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
804PDF: 511HTML: 6297 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2376PDF: 1078HTML: 1998 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
2155PDF: 901HTML: 273 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4257PDF: 1255HTML: 2136Fig.1: 250Fig. 2: 147Table 1: 256Table2: 278Table 3: 265 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4643PDF: 1850HTML: 1136 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
4027PDF: 1795HTML: 11981Figures Haase: 308 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3866PDF: 2671HTML: 1718 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1327PDF: 660HTML: 6943 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1512PDF: 660Suppl. Files: 401HTML: 186 -
ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS
1587PDF: 987HTML: 2029 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3590PDF: 2115HTML: 7594 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3681PDF: 1385HTML: 2421Fi.1 Gritti.Rambaldi: 270 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2644PDF: 987HTML: 2587 -
-
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1658PDF: 1042HTML: 274







